Increased production of intestinal immunoglobulins in Syntenin-1-deficient mice

Immunobiology

Volumn 220, Issue 5, 2015, Pages 597-604

  Tamura, Kentaro ^a   Ikutani, Masashi ^a   Yoshida, Taketoshi ^a   Tanaka Hayashi, Ayumi ^a   Yanagibashi, Tsutomu ^a   Inoue, Ran ^a   Nagai, Yoshinori ^a   Adachi, Yuichi ^a   Miyawaki, Toshio ^a   Takatsu, Kiyoshi ^a   Mori, Hisashi ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

Author keywords

Antibodies; B cells; Knockout mice; Mucosal immunity; Syntenin 1

Indexed keywords

IMMUNOGLOBULIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN M; INTERLEUKIN 5; INTERLEUKIN 5 RECEPTOR ALPHA; SYNTENIN; SYNTENIN 1; UNCLASSIFIED DRUG; SDCBP PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; HOMEOSTASIS; IMMUNOGLOBULIN PRODUCTION; IMMUNOREGULATION; IMMUNOSTIMULATION; IN VITRO STUDY; INNATE IMMUNITY; INTESTINE FLORA; INTESTINE MUCOSA; INTRACELLULAR SIGNALING; KNOCKOUT MOUSE; LAMINA PROPRIA; MALE; MOUSE; MUCOSAL IMMUNITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; SYNTETIN 1 GENE; TISSUE DISTRIBUTION; ANIMAL; ANTIBODY PRODUCTION; BIOSYNTHESIS; C57BL MOUSE; GENETICS; IMMUNOLOGY; INTESTINE; METABOLISM; MICROBIOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; ANTIBODY FORMATION; GASTROINTESTINAL MICROBIOME; HOMEOSTASIS; IMMUNITY, MUCOSAL; IMMUNOGLOBULINS; INTERLEUKIN-5; INTESTINES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; SIGNAL TRANSDUCTION; SYNTENINS;

EID: 84926407723     PISSN: 01712985     EISSN: 18783279     Source Type: Journal    
DOI: 10.1016/j.imbio.2014.12.003     Document Type: Article

References (48)

1. Alewine C., Olsen O., Wade J.B., Welling P.A. TIP-1 has PDZ scaffold antagonist activity. Mol. Biol. Cell 2006, 17:4200-4211.
2. Baietti M.F., Zhang Z., Mortier E., Melchior A., Degeest G., Geeraerts A., Ivarsson Y., Depoortere F., Coomans C., Vermeiren E., Zimmermann P., David G. Syndecan-syntenin-ALIX regulates the biogenesis of exosomes. Nat. Cell Biol. 2012, 14:677-685.
3. Beekman J.M., Verhagen L.P., Geijsen N., Coffer P.J. Regulation of myelopoiesis through syntenin-mediated modulation of IL-5 receptor output. Blood 2009, 114:3917-3927.
4. Beekman J.M., Vervoort S.J., Dekkers F., van Vessem M.E., Vendelbosch S., Brugulat-Panes A., van Loosdregt J., Braat A.K., Coffer P.J. Syntenin-mediated regulation of Sox4 proteasomal degradation modulates transcriptional output. Oncogene 2012, 31:2668-2679.
5. Boukerche H., Su Z.Z., Emdad L., Baril P., Balme B., Thomas L., Randolph A., Valerie K., Sarkar D., Fisher P.B. mda-9/Syntenin: a positive regulator of melanoma metastasis. Cancer Res. 2005, 65:10901-10911.
6. Boukerche H., Su Z.Z., Emdad L., Sarkar D., Fisher P.B. mda-9/Syntenin regulates the metastatic phenotype in human melanoma cells by activating nuclear factor-kappaB. Cancer Res. 2007, 67:1812-1822.
7. Boukerche H., Su Z.Z., Prevot C., Sarkar D., Fisher P.B. mda-9/Syntenin promotes metastasis in human melanoma cells by activating c-Src. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:15914-15919.
8. Chen F., Du Y., Zhang Z., Chen G., Zhang M., Shu H.B., Zhai Z., Chen D. Syntenin negatively regulates TRAF6-mediated IL-1R/TLR4 signaling. Cell. Signal 2008, 20:666-674.
9. Chimura T., Launey T., Ito M. Evolutionarily conserved bias of amino-acid usage refines the definition of PDZ-binding motif. BMC Genomics 2011, 12:300.
10. Das S.K., Bhutia S.K., Kegelman T.P., Peachy L., Oyesanya R.A., Dasgupta S., Sokhi U.K., Azab B., Dash R., Quinn B.A., Kim K., Barral P.M., Su Z.Z., Boukerche H., Sarkar D., Fisher P.B. MDA-9/syntenin: a positive gatekeeper of melanoma metastasis. Front. Biosci. 2012, 17:1-15.
11. Estrach S., Legg J., Watt F.M. Syntenin mediates Delta1-induced cohesiveness of epidermal stem cells in culture. J. Cell Sci. 2007, 120:2944-2952.
12. Fagarasan S., Muramatsu M., Suzuki K., Nagaoka H., Hiai H., Honjo T. Critical roles of activation-induced cytidine deaminase in the homeostasis of gut flora. Science 2002, 298:1424-1427.
13. Fukaya M., Tsujita M., Yamazaki M., Kushiya E., Abe M., Akashi K., Natsume R., Kano M., Kamiya H., Watanabe M., Sakimura K. Abundant distribution of TARP gamma-8 in synaptic and extrasynaptic surface of hippocampal neurons and its major role in AMPA receptor expression on spines and dendrites. Eur. J. Neurosci. 2006, 24:2177-2190.
14. Geijsen N., Uings I.J., Pals C., Armstrong J., McKinnon M., Raaijmakers J.A., Lammers J.W., Koenderman L., Coffer P.J. Cytokine-specific transcriptional regulation through an IL-5Ralpha interacting protein. Science 2001, 293:1136-1138.
15. Gordon-Alonso M., Rocha-Perugini V., Alvarez S., Moreno-Gonzalo O., Ursa A., Lopez-Martin S., Izquierdo-Useros N., Martinez-Picado J., Munoz-Fernandez M.A., Yanez-Mo M., Sanchez-Madrid F. The PDZ-adaptor protein syntenin-1 regulates HIV-1 entry. Mol. Biol. Cell 2012, 23:2253-2263.
16. Grootjans J.J., Zimmermann P., Reekmans G., Smets A., Degeest G., Durr J., David G. Syntenin, a PDZ protein that binds syndecan cytoplasmic domains. Proc. Natl. Acad. Sci. U. S. A. 1997, 94:13683-13688.
17. Gupta S., Braun A., Morowski M., Premsler T., Bender M., Nagy Z., Sickmann A., Hermanns H.M., Bosl M., Nieswandt B. CLP36 is a negative regulator of glycoprotein VI signaling in platelets. Circ. Res. 2012, 111:1410-1420.
18. Helgeland L., Tysk C., Jarnerot G., Kett K., Lindberg E., Danielsson D., Andersen S.N., Brandtzaeg P. IgG subclass distribution in serum and rectal mucosa of monozygotic twins with or without inflammatory bowel disease. Gut 1992, 33:1358-1364.
19. Hirbec H., Martin S., Henley J.M. Syntenin is involved in the developmental regulation of neuronal membrane architecture. Mol. Cell. Neurosci. 2005, 28:737-746.
20. Hiroi T., Yanagita M., Iijima H., Iwatani K., Yoshida T., Takatsu K., Kiyono H. Deficiency of IL-5 receptor alpha-chain selectively influences the development of the common mucosal immune system independent IgA-producing B-1 cell in mucosa-associated tissues. J. Immunol. 1999, 162:821-828.
21. Horton R.E., Vidarsson G. Antibodies and their receptors: different potential roles in mucosal defense. Front. Immunol. 2013, 4:200.
22. Jannatipour M., Dion P., Khan S., Jindal H., Fan X., Laganiere J., Chishti A.H., Rouleau G.A. Schwannomin isoform-1 interacts with syntenin via PDZ domains. J. Biol. Chem. 2001, 276:33093-33100.
23. Jeon H.Y., Das S.K., Dasgupta S., Emdad L., Sarkar D., Kim S.H., Lee S.G., Fisher P.B. Expression patterns of MDA-9/syntenin during development of the mouse embryo. J. Mol. Histol. 2013, 44:159-166.
24. Kopf M., Brombacher F., Hodgkin P.D., Ramsay A.J., Milbourne E.A., Dai W.J., Ovington K.S., Behm C.A., Kohler G., Young I.G., Matthaei K.I. IL-5-deficient mice have a developmental defect in CD5+ B-1 cells and lack eosinophilia but have normal antibody and cytotoxic T cell responses. Immunity 1996, 4:15-24.
25. Koroll M., Rathjen F.G., Volkmer H. The neural cell recognition molecule neurofascin interacts with syntenin-1 but not with syntenin-2, both of which reveal self-associating activity. J. Biol. Chem. 2001, 276:10646-10654.
26. Lin J.J., Jiang H., Fisher P.B. Melanoma differentiation associated gene-9, mda-9, is a human gamma interferon responsive gene. Gene 1998, 207:105-110.
27. Macpherson A., Khoo U.Y., Forgacs I., Philpott-Howard J., Bjarnason I. Mucosal antibodies in inflammatory bowel disease are directed against intestinal bacteria. Gut 1996, 38:365-375.
28. Matsuki T., Watanabe K., Fujimoto J., Kado Y., Takada T., Matsumoto K., Tanaka R. Quantitative PCR with 16S rRNA-gene-targeted species-specific primers for analysis of human intestinal bifidobacteria. Appl. Environ. Microbiol. 2004, 70:167-173.
29. Matsuki T., Watanabe K., Fujimoto J., Miyamoto Y., Takada T., Matsumoto K., Oyaizu H., Tanaka R. Development of 16S rRNA-gene-targeted group-specific primers for the detection and identification of predominant bacteria in human feces. Appl. Environ. Microbiol. 2002, 68:5445-5451.
30. Mita S., Tominaga A., Hitoshi Y., Sakamoto K., Honjo T., Akagi M., Kikuchi Y., Yamaguchi N., Takatsu K. Characterization of high-affinity receptors for interleukin 5 on interleukin 5-dependent cell lines. Proc. Natl. Acad. Sci. U. S. A. 1989, 86:2311-2315.
31. Miya K., Inoue R., Takata Y., Abe M., Natsume R., Sakimura K., Hongou K., Miyawaki T., Mori H. Serine racemase is predominantly localized in neurons in mouse brain. J. Comp. Neurol. 2008, 510:641-654.
32. Moon B.G., Takaki S., Miyake K., Takatsu K. The role of IL-5 for mature B-1 cells in homeostatic proliferation, cell survival, and Ig production. J. Immunol. 2004, 172:6020-6029.
33. Ohno K., Koroll M., El Far O., Scholze P., Gomeza J., Betz H. The neuronal glycine transporter 2 interacts with the PDZ domain protein syntenin-1. Mol. Cell. Neurosci. 2004, 26:518-529.
34. Pols M.S., Klumperman J. Trafficking and function of the tetraspanin CD63. Exp. Cell Res. 2009, 315:1584-1592.
35. Saeland E., Vidarsson G., Leusen J.H., Van Garderen E., Nahm M.H., Vile-Weekhout H., Walraven V., Stemerding A.M., Verbeek J.S., Rijkers G.T., Kuis W., Sanders E.A., Van De Winkel J.G. Central role of complement in passive protection by human IgG1 and IgG2 anti-pneumococcal antibodies in mice. J. Immunol. 2003, 170:6158-6164.
36. Sala-Valdes M., Gordon-Alonso M., Tejera E., Ibanez A., Cabrero J.R., Ursa A., Mittelbrunn M., Lozano F., Sanchez-Madrid F., Yanez-Mo M. Association of syntenin-1 with M-RIP polarizes Rac-1 activation during chemotaxis and immune interactions. J. Cell Sci. 2012, 125:1235-1246.
37. Schilham M.W., Oosterwegel M.A., Moerer P., Ya J., de Boer P.A., van de Wetering M., Verbeek S., Lamers W.H., Kruisbeek A.M., Cumano A., Clevers H. Defects in cardiac outflow tract formation and pro-B-lymphocyte expansion in mice lacking Sox-4. Nature 1996, 380:711-714.
38. Sira M.M., Yoshida T., Takeuchi M., Kashiwayama Y., Futatani T., Kanegane H., Sasahara A., Ito Y., Mizuguchi M., Imanaka T., Miyawaki T. A novel immunoregulatory protein in human colostrum, syntenin-1, for promoting the development of IgA-producing cells from cord blood B cells. Int. Immunol. 2009, 21:1013-1023.
39. Stapleton N.M., Andersen J.T., Stemerding A.M., Bjarnarson S.P., Verheul R.C., Gerritsen J., Zhao Y., Kleijer M., Sandlie I., de Haas M., Jonsdottir I., van der Schoot C.E., Vidarsson G. Competition for FcRn-mediated transport gives rise to short half-life of human IgG3 and offers therapeutic potential. Nat. Commun. 2011, 2:599.
40. Stephenson L.M., Sammut B., Graham D.B., Chan-Wang J., Brim K.L., Huett A.S., Miletic A.V., Kloeppel T., Landry A., Xavier R., Swat W. DLGH1 is a negative regulator of T-lymphocyte proliferation. Mol. Cell. Biol. 2007, 27:7574-7581.
41. Strugnell R.A., Wijburg O.L. The role of secretory antibodies in infection immunity. Nat. Rev. Microbiol. 2010, 8:656-667.
42. Sun B., Mallampati S., Gong Y., Wang D., Lefebvre V., Sun X. Sox4 is required for the survival of pro-B cells. J. Immunol. 2013, 190:2080-2089.
43. Suzuki K., Meek B., Doi Y., Muramatsu M., Chiba T., Honjo T., Fagarasan S. Aberrant expansion of segmented filamentous bacteria in IgA-deficient gut. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:1981-1986.
44. Taniguchi M., Sanbo M., Watanabe S., Naruse I., Mishina M., Yagi T. Efficient production of Cre-mediated site-directed recombinants through the utilization of the puromycin resistance gene, pac: a transient gene-integration marker for ES cells. Nucleic Acids Res. 1998, 26:679-680.
45. Thoree V.C., Golby S.J., Boursier L., Hackett M., Dunn-Walters D.K., Sanderson J.D., Spencer J. Related IgA1 and IgG producing cells in blood and diseased mucosa in ulcerative colitis. Gut 2002, 51:44-50.
46. Tominaga A., Takaki S., Koyama N., Katoh S., Matsumoto R., Migita M., Hitoshi Y., Hosoya Y., Yamauchi S., Kanai Y., et al. Transgenic mice expressing a B cell growth and differentiation factor gene (interleukin 5) develop eosinophilia and autoantibody production. J. Exp. Med. 1991, 173:429-437.
47. Yoshida T., Ikuta K., Sugaya H., Maki K., Takagi M., Kanazawa H., Sunaga S., Kinashi T., Yoshimura K., Miyazaki J., Takaki S., Takatsu K. Defective B-1 cell development and impaired immunity against Angiostrongylus cantonensis in IL-5R alpha-deficient mice. Immunity 1996, 4:483-494.
48. Zimmermann P., Zhang Z., Degeest G., Mortier E., Leenaerts I., Coomans C., Schulz J., N'Kuli F., Courtoy P.J., David G. Syndecan recycling is controlled by syntenin-PIP2 interaction and Arf6. Dev. Cell 2005, 9:377-388.